Nikki Schindler was just 10 years old when she was diagnosed with a Medulloblastoma, a rare form of brain cancer. Since then, Nikki has used her voice to advocate and raise funds for childhood cancer research.
Browse Radiation Oncology News
Novel protocol significantly improves outcomes in locally advanced pancreatic cancer - Massachusetts General Hospital, Boston, MA
A Massachusetts General Hospital clinical trial of a treatment protocol for pancreatic cancer has produced unprecedented results – allowing complete removal of the tumor in 61 percent of participants and significantly improving survival rates.
Tumor-selective angiotensin blockers may improve response to cancer immunotherapy - Massachusetts General Hospital, Boston, MA
A research team led by investigators at Massachusetts General Hospital and the Massachusetts Institute of Technology has found that combining a specialized version of an antihypertension drug with immune checkpoint blockers could increase the effectiveness of cancer immunotherapies.
Study reveals how brain tumors escape the effects of antiangiogenic drugs - Massachusetts General Hospital, Boston, MA
A study led by investigators from Massachusetts General Hospital and the University of Cyprus reveals details of a way the dangerous brain tumors called glioblastomas resist the effects of antiangiogenic drugs designed to cut off their blood supply, identifying what may be a new treatment target.
Blocking pro-fibrosis signaling pathway may improve immunotherapy of metastatic breast cancer - Massachusetts General Hospital, Boston, MA
A Massachusetts General Hospital research team has found that the overgrowth of connective called fibrosis may block the effectiveness of immunotherapies against metastatic breast cancer and that treatment with plerixafor can reduce fibrosis and improve response to immunotherapy in mouse models.
Antihypertension drug losartan may improve treatment of ovarian cancer - Massachusetts General Hospital, Boston, MA
A new study from a Massachusetts General Hospital research team has found that the hypertension drug losartan, which targets the angiotensin signaling pathway, may improve the effectiveness of chemotherapy agents used to treat ovarian cancer.
Mass. General study reveals how solid stress from brain tumors causes neuronal loss, neurologic dysfunction - Massachusetts General Hospital, Boston, MA
A Massachusetts General Hospital (MGH)-led research team has demonstrated, for the first time, how solid stress – the physical forces exerted by the solid components of a tumor – impacts the tissue surrounding brain tumors and contributes to resulting neurological dysfunction and neuronal cell death.
Three researchers from Massachusetts General Hospital were included in the 2018 class of STAT Wunderkinds. The awards were founded to recognize up-and-coming doctors and researchers who are on the cusp of launching their careers.
Pediatric patients throughout MassGeneral Hospital for Children participated in frightful - yet fun - festivities during the Halloween season.
Mass. General study defines mechanisms behind focused-ultrasound-assisted treatment of brain tumors - Massachusetts General Hospital, Boston, MA
A study led by a team of Massachusetts General Hospital investigators has analyzed, for the first time, the mechanisms underlying the use of focused ultrasound to improve the delivery of anti-cancer drugs across the blood brain barrier into brain tumors.